About this trial
This study is being done to demonstrate the effectiveness of Regenerative Peripheral Nerve Interfaces (RPNI) surgery in treating symptomatic neuromas of the hand and digits following amputation compared to standard of care using a Prospective, Observational Trial
Eligibility criteria
Qualifiers
18 years or older
History of unilateral digit, multiple digit, or partial hand amputation
Discrete neuroma pain on clinical exam
Following standard of care (SOC), confirmation through a local block and/or ultrasound imaging will be performed if indicated
Disqualifiers
Patients with previous surgical treatment for symptomatic neuromas of the digits or hand
Patients with other major injuries more proximal in the ipsilateral extremity that cause chronic pain or functional loss
women pregnant at time of enrollment
prisoners
Trial design
Treatments tested in this trial
- Regenerative Peripheral Nerve Interface (RPNI) surgery
- Traction Neurectomy
Treatment groups
Sponsors and collaborators
Medstar Health Research Institute
Lead sponsor
United States Department of Defense
Collaborator
University of Michigan
Collaborator